Risk factors and outcome of hyperammonaemia in people with epilepsy

BACKGROUND: Hyperammonaemia is a recognised complication of antiseizure treatment but risk factors leading to individual patient susceptibility and outcome remain unclear. OBJECTIVE: To identify risk factors for hyperammonaemia and investigate the impact of its management on clinical outcomes. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Vakrinou, Angeliki, Murphy, Elaine, Sisodiya, Sanjay M., Vivekananda, Umesh, Balestrini, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618503/
https://www.ncbi.nlm.nih.gov/pubmed/35907043
http://dx.doi.org/10.1007/s00415-022-11304-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618503/
https://www.ncbi.nlm.nih.gov/pubmed/35907043
http://dx.doi.org/10.1007/s00415-022-11304-7

Ejemplares similares